The historical rank and industry rank for Sun Pharma Advanced Research Co's FCF Margin % or its related term are showing as below:
BOM:532872'
s FCF Margin % Range Over the Past 10 Years
Min: -603.21 Med: -138.31 Max: -13.97
Current: -13.97
During the past 13 years, the highest FCF Margin % of Sun Pharma Advanced Research Co was -13.97%. The lowest was -603.21%. And the median was -138.31%.
BOM:532872's FCF Margin % is ranked worse than 77.62% of 956
companies
in the Drug Manufacturers industry
Industry Median: 2.48
vs BOM:532872: -13.97
Sun Pharma Advanced Research Co FCF Margin % Related Terms
Sun Pharma Advanced Research Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sun Pharma Advanced Research Co FCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharma Advanced Research Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sun Pharma Advanced Research Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sun Pharma Advanced Research Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Sun Pharma Advanced Research Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sun Pharma Advanced Research Co (BOM:532872) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sun Pharma Advanced Research Co and its competitors. According to the industry distribution chart, Sun Pharma Advanced Research Co ranks #742 out of 956 companies in the Drug Manufacturers industry, placing it in the top 77.6%.
Is Sun Pharma Advanced Research Co's FCF Margin % too high?
Sun Pharma Advanced Research Co's current FCF Margin % is 0.00%. Based on the distribution chart, Sun Pharma Advanced Research Co ranks #742 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sun Pharma Advanced Research Co has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sun Pharma Advanced Research Co's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sun Pharma Advanced Research Co ranks #742 out of 956 companies for FCF Margin %. This places Sun Pharma Advanced Research Co in the lower half of its industry. The industry median FCF Margin % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.48, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Sun Pharma Advanced Research Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sun Pharma Advanced Research Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharma Advanced Research Co stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharma Advanced Research Co (BOM:532872) is currently considered Possible Value Trap. The stock's GF Value™ is ₹4,474.78, compared to a current price of ₹231.50 — trading 94.8% below its estimated fair value. The current FCF Margin % is 0.00%. Sun Pharma Advanced Research Co's overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Sun Pharma Advanced Research Co (BOM:532872), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sun Pharma Advanced Research Co (BOM:532872) Overvalued in 2026?
Based on GuruFocus' analysis, Sun Pharma Advanced Research Co stock appears to be undervalued.
The current stock price of ₹231.50 is trading 94.8% below its estimated GF Value™ of ₹4,474.78.
GuruFocus considers Sun Pharma Advanced Research Co to be Possible Value Trap.
Key valuation signals for BOM:532872:
FCF Margin %: 0.00%
GF Value™: ₹4,474.78 vs. price of ₹231.50 (94.8% below fair value)
No single metric tells the full story. See the BOM:532872 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sun Pharma Advanced Research Co Business Description
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in other countries.
52GF Score
Get the complete analysis for BOM:532872
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532872 has been successfully added to your 
